Jain Global’s Fractyl Health GUTS Stock Holding History

Jain Global’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-32,929	Closed	-$53.3K	–	1579
2025 Q2	$53.3K	Buy	+32,929	New	+$53.2K	﹤0.01%	1089

Other funds holding GUTS

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Alyeska Investment Group

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Jain Global's GUTS Position: Q3 2025 in Review

Jain Global sold out of Fractyl Health (GUTS) in Q3 2025, closing a stake of 32,929 shares — an estimated $53.3K sold.

Jain Global first reported a position in GUTS in Q2 2025 and held it in 1 quarter. The position peaked at $53.3K in Q2 2025. 74 funds tracked by Wall St. Rank hold GUTS as of Q3 2025.

Jain Global reported no remaining Fractyl Health position as of Q3 2025 after selling out during the quarter.
Jain Global sold 32,929 Fractyl Health shares in Q3 2025, an estimated $53.3K.
Jain Global first reported a position in Fractyl Health in Q2 2025 and held it in 1 quarter.
Jain Global's Fractyl Health position peaked at $53.3K in Q2 2025.
74 funds tracked by Wall St. Rank held Fractyl Health as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.